ClinicalTrials.gg
CompletedNCT03481270Updated Oct 25, 2019Results posted

The Oakland Men's Health Disparities Study

An interventional study of Concordant in Behavior, Cardiovascular Risk Factor and Influenza, sponsored by Stanford University. Completed at 1 site in United States. Open to male participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-25.

Sponsored by Stanford University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,374
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
Male
01

Study summary

Reducing racial disparities in health outcomes is a major policy concern in the United States. Although there has been recent progress to close the gap, black men continue to experience earlier morbidity and mortality from preventable and manageable medical conditions, and live on average 4.2 years less than their white male peers. An oft-prescribed solution to close this stubborn gap is to increase the diversity of the healthcare workforce. Another common policy tool to increase take-up of preventative healthcare services is financial incentives. In this randomized evaluation, we will estimate the effects of financial incentives and a racially concordant physician on the uptake of preventive health services in Oakland, California.

02

Conditions studied

  • Behavior
  • Cardiovascular Risk Factor
  • Influenza
03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 1,374 is above the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Stanford University is the lead sponsor of 2,168 studies on the registry; 431 are open to participants now.

Of its 267 completed or terminated interventional studies of FDA-regulated products, 207 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • African American male adults

Exclusion criteria

Exclusion Criteria:

-

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
1,374 participants (actual)

Study arms

  • Placebo comparator
    Discordant

    Does not receive the concordant provider.

    Behavioral: Concordant

  • Experimental
    Concordant

    The intervention is that the subject receives the concordant provider.

    Behavioral: Concordant

Interventions

  • BehavioralConcordant

    We will be randomizing across providers - we are particularly interested in racial concordance.

06

What researchers measure

Primary outcomes

  1. Average Take-up of Preventive Services (Post-consultation)

    Take-up of preventative services was scored as either zero (did not utilize any post-consultation services) or 1 (utilized at least 1 post-consultation service). Four non-incentivized post-consultation preventive services were offered (for BMI, blood pressure, cholesterol, and/or diabetes); the subject had the opportunity to select service(s) after meeting with their assigned doctor.

    Time frame: 1 day

07

Results

Posted Oct 25, 2019

Participant flow

We recruited 1374 black men in barbershops and flea markets to take the baseline survey. The subjects were given a coupon which allowed them entrance to the clinic.

Participant flow — Overall Study
MilestoneDiscordantConcordant
Started324313
Completed324313
Not completed00

Outcome measures

PrimaryAverage Take-up of Preventive Services (Post-consultation)

Take-up of preventative services was scored as either zero (did not utilize any post-consultation services) or 1 (utilized at least 1 post-consultation service). Four non-incentivized post-consultation preventive services were offered (for BMI, blood pressure, cholesterol, and/or diabetes); the subject had the opportunity to select service(s) after meeting with their assigned doctor.

Time frame:
1 day
Reported as:
Mean · score on a scale
Average Take-up of Preventive Services (Post-consultation)
score on a scaleDiscordantConcordant
Average Take-up of Preventive Services (Post-consultation)0.52 ± .36.71 ± .36

Adverse events

Collected over 1 day. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Discordant0/324 (0%)0/324 (0%)0/324 (0%)
Concordant0/313 (0%)0/313 (0%)0/313 (0%)

Baseline characteristics

Numbers are those who presented to the clinic and who met study criteria (African-American, age 18+, male)

Age, Continuous
Age, Continuous(years)DiscordantConcordantTotal
Mean43.4 ± 16.342.6 ± 17.143.0 ± 16.7
Sex: Female, Male
Sex: Female, Male(Participants)DiscordantConcordantTotal
Female000
Male324313637
Race (NIH/OMB)
Race (NIH/OMB)(Participants)DiscordantConcordantTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American324313637
White000
More than one race000
Unknown or Not Reported000
Average education level
Average education level(score on a scale)DiscordantConcordantTotal
Mean.62 ± .49.64 ± .48.63 ± .48
08

Study locations

1 site
  • Barbershops / Fleamarkets
    Oakland, California 94577, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03481270
Responsible party
Marcella Alsan (Assistant Professor, Stanford University) — Principal investigator
First posted
Mar 29, 2018
Start date
Oct 14, 2017
Primary completion
Mar 3, 2018
Completion
Mar 3, 2018
Results posted
Oct 25, 2019
Last update
Oct 25, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion